eli lilly retatrutide study Lilly's Phase 3 clinical studies investigating retatrutide, the "triple-G" agonist, have found that long-term use can achieve substantial weight loss. Read about the work via the link in the comments A Study of Retatrutide (LY3437943)

The closed conformation of the peptide-free GLP-1R compared to GCGR is quite divergent in the extracellular region and may be a consequence of sequence diversity, which is important for understanding the signalling pathway for different receptors within the class B family

Human hearts with ischemic, dilated, and hypertrophic cardiomyopathy demonstrate upregulated GLP-1R expression in cardiomyocytes compared to non-failing hearts [2]

Are Vitamin D injections safe

Ensure protein intake stays at target despite reduced hunger

The behaviors you establish while on the medication form the foundation for whatever comes next